Pfizer’s strategy chief Andrew Baum steps down; Helus Pharma swaps out CEO after two months

April 24, 2026 07:00 AM EDT Peer Review Pfiz­er’s strat­e­gy chief An­drew Baum steps down; Helus Phar­ma swaps out CEO af­ter two months Alex Hoffman Copy Chief Kyle LaHucik Biotech Correspondent Max Bayer Senior Reporter → Ex-Citi an­a­lyst An­drew Baum has left his role as chief strat­e­gy and in­no­va­tion of­fi­cer at Pfiz­er, but he will be a se­nior strate­gic ad­vi­sor … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER